| 摘要 |
FIELD: medicine.SUBSTANCE: co-infected patients are examined to assess the dynamics of immunological markers of interferon ? (IFN?), interferon ? (IFN?) and interleukin 4 (IL-4) and their monitoring before therapy and 4 weeks after the beginning of the therapy. A stable remission is predicted if the initial cytokine count is more than 3.99 pg/ml for IFN?, from 8.32 to 13.1 pg/ml for IFN?, if the IFN?/IL-4 ratio is more than 6.72, whereas IFN? tends to increase as many as 100 times 4 weeks after the beginning of the therapy with IFN? of 8.32 to 13.1 pg/ml, and the IFN?/IL-4 ratio keeps increasing in the course of treatment by more than 6.72.EFFECT: using the given method enables the early prediction of the clinical outcome of antiviral therapy in HIV patients.2 ex, 4 tbl, 3 dwg |
